http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100016171-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a57ba74d4e5ac4f65e5c78733a07b3a1 |
| publicationDate | 2010-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100016171-A |
| titleOfInvention | Use of HADAC inhibitors for the treatment of gastrointestinal cancer |
| abstract | The present invention provides the use of an HDAC inhibitor for the manufacture of a medicament for the treatment of gastrointestinal cancer; A method of treating a warm blooded animal suffering from gastrointestinal cancer, in particular a human, a warm blooded animal suffering from gastrointestinal cancer comprising administering a therapeutically effective amount of an HDAC inhibitor, in particular a compound of formula (I) as defined herein; And pharmaceutical compositions and commercial packages. |
| priorityDate | 2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467259576 |
Total number of triples: 15.